Nonetheless, the use of oral contraceptives as prevention for ovarian cancer is not permitted, because it is known to increase the risk of breast cancer in the general population but not in the BRCA1/2 mutation carriers, although the latter correlation cannot be excluded [13], as well as the risk of cervical cancer [18]. The gene discussed is BRCA1; the disease is breast carcinoma.